AnaptysBio Inc.'s Lead Candidate Gets New Priorities -- The Motley Fool

AnaptysBio Inc.'s Lead Candidate Gets New Priorities -- The Motley Fool

Source: 
Motley Fool
snippet: 

AnaptysBio Inc. (NASDAQ:ANAB) earnings reports have been fairly uneventful affairs while we wait for results from ongoing studies, but the company was able to let investors know it wouldn't be diverting any more resources toward a peanut allergy indication for its lead candidate after reporting less than thrilling mid-stage results earlier this year.